Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Modified leukocyte ig-like receptor family members (LIR'S) with increased affinity for class I MHC and their uses in modulating T cell activation

A cell-use technology, applied in the field of modified leukocyte Ig-like receptor family (LIR'S) with improved affinity for class I MHC and its use in regulating T cell activity, can solve problems such as slow affinity dissociation rate

Inactive Publication Date: 2008-09-17
麦迪金有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, for this purpose it is desirable if these polypeptides have a higher affinity for the target pMHC molecule and / or a slower off-rate than the native ILT molecule

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Modified leukocyte ig-like receptor family members (LIR'S) with increased affinity for class I MHC and their uses in modulating T cell activation
  • Modified leukocyte ig-like receptor family members (LIR'S) with increased affinity for class I MHC and their uses in modulating T cell activation
  • Modified leukocyte ig-like receptor family members (LIR'S) with increased affinity for class I MHC and their uses in modulating T cell activation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0154] Example 1 - Preparation of Soluble Wild-Type ILT-2 Molecules Containing Domains 1 and 2

[0155] image 3 (SEQ ID NO: 5) provides the DNA sequence used to express soluble wild-type ILT-2 containing only domains D1 and D2. These DNA sequences can be synthesized de novo by various contract research companies, eg GeneArt (Germany). Restriction enzyme recognition sites (NdeI and HindIII) were introduced into this DNA sequence, thereby facilitating the ligation of these DNA sequences into a pGMT7-based expression plasmid containing the gene for high-level expression in E. coli strain BL21-DE3 (pLysS). Expressed T7 promoter (Pan et al., Biotechniques (2000) 29(6):1234-8).

[0156] The DNA sequence is connected into the pGMT7 carrier cut with NdeI and HindIII (the DNA sequence of the carrier is shown in Figure 6 , see the plasmid map of this vector Figure 7 ).

[0157] Introduction of a restriction enzyme recognition site into DNA encoding a soluble wild-type ILT-2 poly...

Embodiment 2

[0164] Example 2 - Preparation of High Affinity Variants of Soluble Wild-Type ILT-2 Polypeptides

[0165] Soluble wild-type ILT-2 polypeptides produced as described in Example 1 can be used as templates from which polypeptides of the invention with increased affinity and / or reduced off-rates for class I pMHC molecules can be generated.

[0166] It is known to those skilled in the art that the necessary codon changes required to generate these mutant chains can be introduced into the DNA encoding the soluble wild-type ILT-2 polypeptide by site-directed mutagenesis (QuickChange TM , Stratagene Site-Directed Mutagenesis Kit).

[0167] Briefly, this is achieved by using primers incorporating the desired codon change(s) and a plasmid containing DNA encoding a soluble wild-type ILT-2 polypeptide as a template for mutagenesis:

[0168] The following conditions were used for mutagenesis: 50ng of plasmid template, 1μl of 10mM dNTP, 5μl of 10×Pfu DNA polymerase buffer provided by the m...

Embodiment 3

[0170] Example 3 - Expression, refolding and purification of soluble polypeptides

[0171] The expression plasmids containing the ILT polypeptide (gene) prepared in Example 1 or 2 were respectively transformed into Escherichia coli strain rosetta DE3pLysS, and cultured in TYP medium (containing 100 μg / ml ampicillin and 15 μg / ml chloramphenicol) at 37°C Single colonies with ampicillin / chloramphenicol resistance were incubated for 7 hours before protein expression was induced with 0.5 mM IPTG. After 15 hours of induction, the cells were collected by centrifugation at 4000 rpm for 30 minutes with a Beckman J-6B. The cell pellet was resuspended in buffer, and the resuspended cells were sonicated for 1 min with a standard 12 mm diameter probe in a Milsonix XL2020 sonicator for a total of about 10 min. The inclusion body precipitate was recovered by centrifugation at 4000 rpm for 10 minutes with a Beckman J2-21 centrifuge. It was then washed three times with detergent to remove ce...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides polypeptides having the property of binding to a given Class I pMHC CHARACTERISED IN THAT said polypeptide has a KD for the said given Class I pMHC of less than or equal to l[mu]M and / or has an off-rate (koff) for the said given Class I pMHC molecule of 2 S<-1> or slower AND said polypeptide has at least a 45 % identity and / or 55 % similarity to SEQ ID NO: 7 AND said polypeptide inhibits CD8 binding to the given pMHC to a greater extent than the polypeptide SEQ ID NO: 3. Such polypeptides are useful, either alone or associated with a therapeutic agent, for the inhibition of cyto-toxic T cell (CTL) responses.

Description

[0001] The present invention relates to a polypeptide having binding properties to a given class I pMHC, characterized in that the polypeptide has a K for the given class I pMHC D Less than or equal to 1 μM and / or the dissociation rate (off-rate, k off ) for 2S -1 Or less, said polypeptide has at least 45% identity and / or 55% similarity to SEQ ID NO:7 and said polypeptide inhibits CD8 binding to the given pMHC to a greater extent than polypeptide SEQ ID NO:3. Also provided are multivalent complexes of the polypeptides, cells presenting the polypeptides, binding the polypeptides to therapeutic agents and methods of using these polypeptides. Background of the invention [0002] Immunoglobulin-like transcript (ILT) is also known as leukocyte immunoglobulin-like receptor (LIR), monocyte / macrophage immunoglobulin-like receptor (MIR), and CD85. This family of immune receptors forms part of the immunoglobulin superfamily. The identification of ILT molecules was published for the f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/705A61K38/17A61P37/00A61K38/00C07K14/735
CPCC07K14/70503C07K14/70535A61K38/00A61P37/00A61P43/00
Inventor B·K·雅各布森李懿R·K·莫伊西
Owner 麦迪金有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com